BioSapien Inc.
PrivateLast Round
VC Round
Jul 7, 2025
Total Funding Raised
$15.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioSapien Inc. is a biotechnology company that develops 3D-printed, biodegradable mesh chips designed to deliver pharmaceuticals directly to tumor sites.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSapien Inc. Comparables
Compare BioSapien Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 89% | |
| RenovoRx | 75% | |
| NanOlogy, LLC | 74% |
BioSapien Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 7, 2025 | ||||
| Early Funding | Jan 27, 2025 | ||||
| Early Funding | Dec 12, 2024 | ||||
| Seed | Nov 11, 2021 | ||||
| Grant | Jun 30, 2021 | ||||
Grant | May 1, 2021 |
BioSapien Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Gate Ventures | Early Funding, VC Round |
| JPIN 1 | VC Round |
| Global Ventures | Early Funding, VC Round |
| Dara Holdings | Early Funding, VC Round |
| Side Door Ventures | Seed |
| Dara Management | Early Funding |
| Globivest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 30% QoQ from 10 to 13 employees.
- Jul 7, 2025
$1M round led by Globivest
Recent news
Latest coverage and updates
- increases_headcount_bySep 10, 2026
BioSapien, Inc. increases headcount by 12.
- recognized_asAug 14, 2026
BioSapien, Inc. recognized as best startup at 2026 PRIX GALIEN USA AWARDS on Aug 14th '26.
BioSapien Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioSapien Inc.'s valuation, stock price, and market status.
Is BioSapien Inc. a public or private company?
BioSapien Inc. is a private company.
What is the current stock price of BioSapien Inc.?
BioSapien Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BioSapien Inc. worth (valuation)?
Valuation information for BioSapien Inc. is not publicly available.
Can I buy BioSapien Inc. stock?
BioSapien Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioSapien Inc.'s last funding round?
BioSapien Inc.'s most recent funding round was Series A Extension on July 7, 2025.
Who are the main investors in BioSapien Inc.?
Key investors in BioSapien Inc. include Global Ventures, Globivest, SOSV, Hikma Ventures.
Will BioSapien Inc. IPO soon?
No public IPO plans have been announced for BioSapien Inc..
How can I track BioSapien Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioSapien Inc.'s secondary market activity and sign up for updates.